Acute increases in night-time plasma melatonin levels following a period of meditation

Biological Psychology

Volumn 53, Issue 1, 2000, Pages 69-78

  Tooley, Gregory A ^a   Armstrong, Stuart M ^b   Norman, Trevor R ^c   Sali, Avni ^b  

^a LA TROBE UNIVERSITY   (Australia)

^b SWINBURNE UNIVERSITY OF TECHNOLOGY   (Australia)

^c UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Circadian rhythms; Meditation; Melatonin; Pineal; Relaxation

Indexed keywords

MELATONIN;

ADULT; ARTICLE; BLOOD LEVEL; CIRCADIAN RHYTHM; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN EXPERIMENT; LIVER METABOLISM; MALE; MEDITATION; NIGHT; NORMAL HUMAN; PINEAL BODY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TIME; TRANSCENDENTAL MEDITATION; YOGA;

ADULT; CIRCADIAN RHYTHM; FEMALE; HUMANS; MALE; MEDITATION; MELATONIN; PINEAL GLAND;

EID: 0034194892     PISSN: 03010511     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0301-0511(00)00035-1     Document Type: Article

References (46)

1. Aoki H., Yamada N., Ozeki Y., Yamane H., Kato N. Minimum light intensity required to suppress nocturnal melatonin concentration in human saliva. Neurosci. Lett. 252:1998;91-94.
2. Arendt J. Role of the pineal gland in seasonal reproductive function in mammals. Clarke J.R. Oxford Reviews of Reproductive Biology. 1986;266-320 Oxford University Press, Oxford, UK.
3. Arendt J. Melatonin and the Mammalian Pineal Gland. 1995;Chapman and Hall, London.
4. Armstrong S.M. Melatonin. the internal zeitgeber of mammals? Pineal Res. Rev. 7:1989;157-202.
5. Bujatti M., Riederer P. Serotonin, noradrenaline, dopamine metabolites in transcendental meditation technique. J. Neural Trans. 39:1976;257-267.
6. Fraser S., Cowen P., Franklin M., Franey C., Arendt J. Direct radioimmunoassay for melatonin in plasma. Clin. Chem. 29:1983;396-399.
7. Gupta D., Attanasio A., Reiter R.J. The Pineal Gland and Cancer. 1988;Tubingen, Bass.
8. Jevning R., Wallace R.K., Beidbach M. The physiology of meditation: a review. a wakeful hypometabolic intergrated response. Neurosci. Biobehav. Rev. 16:1992;415-424.
9. Jevning R., Wilson A.F., Davidson J.M. Adrenocortical activity during meditation. Hormones Behav. 10:1978;54-60.
10. Jevning R., Wilson A.F., Smith W.R., Morton M.E. Redistribution of blood flow in acute hypometabolic behaviour. Am. J. Physiol. 235:1978;R89-R92.
11. Jimmerson D.C., Lynch H.J., Post R.M., Wurtman R.J., Bunney W.E. Urinary melatonin rhythms during sleep deprivation in depressed patients and normals. Life Sci. 20:1977;1501.
12. Klein D.C. Photoneural regulation of the mammalian pineal gland. Evered D., Clarke S. Photoperiodism, Melatonin and the Pineal. 1985;38-51 Pitman, London.
13. Lang R., Dehof K., Meurer K.A., Kaufmann W. Sympathetic activity and transcendental meditation. J. Neural Trans. 44:1979;117-135.
14. Lerner A.B., Case J.B., Takahashi Y., Lee T.H., Mori W.H. Isolation of melatonin, the pineal gland factor that lightens melanocytes. J. Am. Chem. Soc. 80:1958;2587.
15. Lewy A.J., Wehr T.A., Goodwin F.K., Newsome D.R., Markey S.P. Light suppresses melatonin secretion in humans. Science. 210:1980;1267-1269.
16. MacLean C.R., Walton K.G., Wenneberg S.R. et al. Effects of the transcendental meditation program on adaptive mechanisms: changes in hormone levels and responses to stress after 4 months of practice. Psychoneuroendocrinology. 22:1997;277-295.
17. Maestroni G.J.M., Conti A., Pierpaoli W. Role of the pineal gland in immunity. J. Neuroimmunol. 13:1986;19-30.
18. Maestroni G.J.M., Conti A., Pierpaoli W. Pineal melatonin, its fundamental role in aging and cancer. Ann. NY Acad. Sci. 521:1988;140-148.
19. Massion A.O., Teas J., Herbert R., Wertheimer M.D., Kabat-Zinn J. Meditation, melatonin and breast/prostate cancer: hypotheses and preliminary data. Med. Hyp. 44:1995;39-46.
20. McIntyre I., Norman T.R., Burrows G.D., Armstrong S.M. Human melatonin suppression by light is intensity dependent. J. Pineal Res. 6:1988;149-156.
21. McIntyre I.M., Norman T.R., Burrows G.D., Armstrong S.M. Quantal suppression of melatonin by exposure to low intensity light in man. Life Sci. 45:1989;327-332.
22. Meares A. Regression of cancer of the rectum after intensive meditation. Med. J. Australia. 2:1979;539-540.
23. Michaels R.R., Huber J.S., McCann D.S. Evaluation of transcendental meditation as a method of reducing stress. Science. 192:1976;1242-1244.
24. Monteleone P., Fuschino A., Nolfe G., Maj M. Temporal relationship between melatonin and cortisol responses to nighttime physical stress in humans. Psychoneuroendocrinology. 17:1992;81-86.
25. Moore R.Y. The innervation of the mammalian pineal gland. Prog. Reprod. Biol. 4:1978;1-29.
26. Moore R.Y., Eichler V.B. Loss of a circadian adrenal corticosterone rhythm following suprachiasmatic lesions in the rat. Brain Res. 42:1972;201-206.
27. Morse D.R., Martin J.S., Furst M.L., Dubin L.L. A physiological and subjective evaluation of meditation, hypnosis and relaxation. Psycho. Med. 39:1977;304-324.
28. Murphy D.L., Garrick N.A., Tamarkin L., Taylor P.L., Markey S.P. Effects of antidepressant and other psychotropic drugs on melatonin release and pineal gland function. J. Neural Trans. 21:1986;291-309.
29. Norman, T.R., McIntyre I., Armstrong, S.M., Unpublished material.
30. Pagano R.R., Rose R.M., Stivers R.M., Warrenberg S. Sleep during transcendental meditation. Science. 191:1976;308-309.
31. Panzer A., Viljoen M. The validity of melatonin as an oncostatic agent. J. Pineal Res. 22(4):1997;184-202.
32. Pierpaoli W. Neuroimmunomodulation of aging. a program in the pineal gland. Ann. NY Acad. Sci. 840:1998;491-497.
33. Pierpaoli W., Maestroni G.J.M. Melatonin a principle neuroimmunoregulatory and anti-stress hormone: its anti-aging effects. Immunol. Lett. 16:1987;355-362.
34. Reiter R., Tang L., Garcia J.J., Munoz-Hoy S.A. Pharmacological actions of melatonin in oxygen radical pathophysiology. Life Sci. 60:1997;2255-2271.
35. Shapiro D.H. Overview: clinical and physiological comparison of meditation with other self-control strategies. Am. J. Psych. 139:1982;267-273.
36. Solberg E.E., Halvorsen R., Sundgot Borgen J., Ingjer F., Holen A. Meditation: a modulator of the immune response to physical stress? a brief report. Br. J. Sports Med. 29(4):1995;255-257.
37. Stephan F.K., Zucker I. Circadian rhythms in drinking behaviour and locomotor activity in rats are eliminated by hypothalamic lesions. Proc. Nat. Acad. Sci. USA. 69:1972;1583-1586.
38. Trinder J., Armstrong S.M., O'Brien C., Luke D., Martin M. Inhibition of melatonin secretion onset by low levels of illumination. J. Sleep Res. 5:1996;77-82.
39. Van Reeth O., Sturis J., Byrne M.M. et al. Nocturnal exercise phase delays circadian rhythms of melatonin and thyrotropin secretion in normal men. Am. J. Physiol. 266:1994;964-974.
40. Vaughan G.M. Human melatonin in physiologic and diseased states: neural control of the rhythm. Wurtman R.J., Waldhauser F. Melatonin in Humans. 1986;199-215 Springer-Verlag, Wein.
41. Vaughan G.M., Bell R., De La Pena A. Nocturnal plasma melatonin in humans: episodic pattern and influence of light. Neurosci. Lett. 14:1979;81-84.
42. Vaughan G.M., Pelham R.W., Pang S.F. et al. Nocturnal elevation of plasma melatonin and urinary 5-hydroxy-indoleacetic acid in young men: attempts at modification by brief changes in environmental lighting and sleep and by autonomic drugs. J. Clin. Endocrinol. Metab. 42:1976;752.
43. Wallace R.K. Physiological effects of transcendental meditation. Science. 167:1970;1751-1754.
44. Wallace R.K. The Neurophysiology Of Enlightenment. 1989;Maharishi International University Press, Fairfield.
45. Wallace R.K., Dillbeck M.C., Jacobe E., Harrington B. The effects of the transcendental meditation and TM-Sidhi program on the aging process. Int. J. Neurosci. 16:1982;53-58.
46. Werner O.R., Wallace R.K., Charles B. et al. Long-term endocrinologic changes in subjects practising the Transcendental Meditation and TM-Sidhi program. Psycho. Med. 48:1986;59-66.